G
Guest
Guest
Read the CBSNEWS article here: http://www.cbsnews.com/8301-504763_162-20061852-10391704.html
That's bad news. I hope Shire gets its act together soon. They've pushed this pills on little kids for decades. /default_angry.png Kids who are now adults and depend on it.Read the CBSNEWS article here: http://www.cbsnews.com/8301-504763_162-20061852-10391704.html
Shire pharmaceuticals is the reason too. They want to get everyone on their Vyvance. If you do a little research, you will be sickened by what you find regarding this, along with Teva/Barr and Dextrostat. I'm surprized Teva doesn't own Shire by now, or maybe they do for all I know. Regardless, it's all about $$$$ and greed!Read the CBSNEWS article here: http://www.cbsnews.com/8301-504763_162-20061852-10391704.html
If ever the truth were told- That's it... and our government won't do a d@mn thing about it even though there is a HUGE conflict of interest (in business terms). I do believe it breaks more than one rule too! But second maybe only to OPEC, Big Pharma runs everything including our so called government. IMHO. Not to mention, shouldn't TEVA qualify as a "monopoly" by now?350, I agree.I have never ever had less than the same results generic vs pretty packaged soooooothing toned commercialized BRAND NAME packaging.
It is the exact same marketing approach for something as mundane as cigars. Same stick in a different box with a different PRETTY cigar label.
Roller do not know what they are rolling. Finer line cigars are often same tobacco guts with a different binder & different wrapper. BIG $$$.
Niche marketing is the marketing plan. I doubt seriously the start up cost of approving two different formulations went into the product life planning. Regulatory apparatus would add the expense that the two formulations legally required 2 rigorous, "to the extent of THE ABSURD" required for USDA approval. That includes the manufacturing equipment etc etc!!!
Only difference is probable the stamp, color and shape of the cap or tablet and the packaging it comes in which generic isn't charging for those insipid commercials 7 pretty pkging.
With the start up cost involved for two distinct formulations, added to the reality of the generic brand market,it only makes good business sense to sell to every aspect of the planned market diagnosed demographic decided before they even make the first move!
Same stuff different suit!!!